Marco Quarta received his doctorate degree in Biotechnology from the University of Bologna and a Ph.D. in Neuroscience from the University of Padua. He completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University. He continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital in Palo Alto, CA. While there, he established a translational program in regenerative medicine. He has over 35 publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation.
Marco also co-founded Turn Biotechnology and served as an executive board member of the European Federation of Biotechnologies. He currently sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) and the the Center for Healthcare Innovation, and is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University.
Marco also co-founded Turn Biotechnology and served as an executive board member of the European Federation of Biotechnologies. He currently sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) and the the Center for Healthcare Innovation, and is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University.
Speaking In
10:30 AM - 10:45 AM (EST)
Monday, February 6
Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of innovative…
Palace
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
